Risperdal Consta will be the first LONG-ACTING injectable ATYPICAL antipsychotic

Risperdal Consta will be the first LONG-ACTING injectable ATYPICAL antipsychotic.

Patients who don't take oral meds consistently can now get a shot every 2 weeks.

Risperdal Consta will come in 25, 37.5, and 50 mg vials.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote